Niagen Bioscience, Inc.
NAGE
Positions held
Your positionsNAGE isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $210.48M | Enterprise value | $146.66M | Trailing P/E | 14.00 | Forward P/E | 26.60 |
| PEG | — | Price / book | 2.55 | Beta | 2.02 | Dividend yield | 0.00% |
| Revenue growth | -4.3% | Earnings growth | -75.0% | Gross margin | 64.2% | Operating margin | 2.4% |
| Profit margin | 12.4% | ROE | 21.8% | ROA | 5.4% | Debt / equity | 0.03 |
| Current ratio | 6.50 | Free cash flow | $1.64M | Analyst recommendation | strong_buy | Mean target | $12.08 |
| 52w high | $7.95 | 52w low | $2.61 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $29.8M | $31.5M | $33.8M | $34.0M | $31.1M | — |
| Op margin | 2.4% | 5.0% | 6.2% | 12.5% | 10.2% | — |
| Net income | $1.0M | $6.3M | $4.1M | $4.6M | $3.6M | — |
| Gross margin | 64.8% | 63.5% | 64.1% | 64.5% | 65.0% | — |
| Gross profit | $19.3M | $20.0M | $21.7M | $21.9M | $20.2M | — |
| Operating income | $0.7M | $1.6M | $2.1M | $4.2M | $3.2M | — |
- Revenue -5% vs prior quarter ($30M vs $31M).
- Gross margin 64.8% (was 63.5% prior quarter).
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $129M | $99.6M | $83.6M | $72.0M | — |
| Op margin | 11.0% | 7.8% | -6.7% | -25.9% | — |
| Net income | $17.4M | $8.6M | -$4.9M | -$16.5M | — |
| Gross margin | 64.3% | 61.8% | 60.8% | 59.4% | — |
| Gross profit | $83.2M | $61.6M | $50.8M | $42.8M | — |
| Operating income | $14.3M | $7.7M | -$5.6M | -$18.6M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-06 · Niagen Bioscience to Present at LD Micro 20th Annual Main Event
2026-09-30 · Niagen Bioscience (NAGE): Can Its NAD+ Business Drive the Next Leg of Growth?
2026-09-10 · Niagen Bioscience to Present at Canaccord Genuity’s Well Summit
2026-09-02 · Niagen Bioscience to Present at Longevity Investors Conference
2026-08-26 · Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit
2026-08-20 · Niagen Bioscience Expands Tru Niagen® Retail Footprint with GNC and Sam’s Club
2026-08-12 · Niagen Bioscience to Present at the 17th Annual Midwest IDEAS Investor Conference
Price (daily)
Full chart · RSI · MACD · patterns